ubenimex

DRUG3 trials

Sponsors

Eiger BioPharmaceuticals

Conditions

LymphedemaPulmonary Arterial Hypertension

Phase 2

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

CompletedNCT02664558

Eiger BioPharmaceuticalsPulmonary Arterial Hypertension

Start: 2016-04-30End: 2018-01-31Updated: 2023-03-06

Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)

CompletedNCT02700529

Eiger BioPharmaceuticalsLymphedema

Start: 2016-06-30End: 2019-02-28Updated: 2023-01-18

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

TerminatedNCT02736149

Eiger BioPharmaceuticalsPulmonary Arterial Hypertension

Start: 2016-12-31End: 2018-08-31Updated: 2023-01-18